Emergence of carbapenem-resistant Pseudomonas alcaligenes and Pseudomonas paralcaligenes clinical isolates with plasmids harbouring bla IMP-1 in Japan.

IF 2.4 4区 医学 Q3 MICROBIOLOGY
Emi Ono, Mari Tohya, Tatsuya Tada, Tomomi Hishinuma, Shin Watanabe, Kyoko Kuwahara-Arai, Teruo Kirikae
{"title":"Emergence of carbapenem-resistant <i>Pseudomonas alcaligenes</i> and <i>Pseudomonas paralcaligenes</i> clinical isolates with plasmids harbouring <i>bla</i> <sub>IMP-1</sub> in Japan.","authors":"Emi Ono,&nbsp;Mari Tohya,&nbsp;Tatsuya Tada,&nbsp;Tomomi Hishinuma,&nbsp;Shin Watanabe,&nbsp;Kyoko Kuwahara-Arai,&nbsp;Teruo Kirikae","doi":"10.1099/jmm.0.001684","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction.</b> The emergence of carbapenem-resistant <i>Pseudomonas</i> species producing metallo-β-lactamase (MBL) has become a serious medical problem worldwide. IMP-type MBL was firstly detected in 1991 in Japan. Since then, it has become one of the most prevalent types of MBLs.<b>Hypothesis/Gap statement.</b> Avirulent species of <i>Pseudomonas</i>, such as <i>Pseudomonas alcaligenes</i>, function as reservoirs of drug resistance-associated genes encoding carbapenemases in clinical settings.<b>Methodology.</b> Active surveillance for carbapenem-resistant Gram-negative pathogens was conducted in 2019 at a hospital in Tokyo, Japan. Of the 543 samples screened for carbapenem-resistant isolates, 2 were species of <i>Pseudomonas</i>. One was from a stool sample from a medical staff member, and the other was from a stool sample from a hospitalized patient.<b>Results.</b> Whole-genome sequencing showed that the former isolate was a strain of <i>P. alcaligenes</i>, and the latter was a strain of <i>Pseudomonas paralcaligenes</i>, a species close to <i>P. alcaligenes</i>. Both isolates were resistant to all carbapenems and harboured <i>bla</i> <sub>IMP-1</sub> genes encoding IMP-1 MBL, which conferred resistance to carbapenems. The <i>bla</i> <sub>IMP-1</sub> genes of <i>P. alcaligenes</i> and <i>P. paralcaligenes</i> were located on the plasmids, pMRCP2, 323125 bp in size, and pMRCP1333, 16592 bp in size, respectively. The sequence of 82 % of pMRCP2 was 92 % similar to the sequence of a plasmid of <i>P. aeruginosa</i> PA83, whereas the sequence of 79 % of pMRCP1333 was >95 % similar to the sequence of a plasmid of <i>Achromobacter xylosoxidans</i> FDAARGOS 162. The genomic environments surrounding the <i>bla</i> <sub>IMP-1</sub> of pMRCP2 and pMRCP1333 differed completely from each other.<b>Conclusions.</b> These results indicate that the two isolates acquired <i>bla</i> <sub>IMP-1</sub> from different sources and that <i>P. alcaligenes</i> and <i>P. paralcaligenes</i> function as vectors and reservoirs of carbapenem-resistant genes in hospitals.</p>","PeriodicalId":16343,"journal":{"name":"Journal of medical microbiology","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of medical microbiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1099/jmm.0.001684","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction. The emergence of carbapenem-resistant Pseudomonas species producing metallo-β-lactamase (MBL) has become a serious medical problem worldwide. IMP-type MBL was firstly detected in 1991 in Japan. Since then, it has become one of the most prevalent types of MBLs.Hypothesis/Gap statement. Avirulent species of Pseudomonas, such as Pseudomonas alcaligenes, function as reservoirs of drug resistance-associated genes encoding carbapenemases in clinical settings.Methodology. Active surveillance for carbapenem-resistant Gram-negative pathogens was conducted in 2019 at a hospital in Tokyo, Japan. Of the 543 samples screened for carbapenem-resistant isolates, 2 were species of Pseudomonas. One was from a stool sample from a medical staff member, and the other was from a stool sample from a hospitalized patient.Results. Whole-genome sequencing showed that the former isolate was a strain of P. alcaligenes, and the latter was a strain of Pseudomonas paralcaligenes, a species close to P. alcaligenes. Both isolates were resistant to all carbapenems and harboured bla IMP-1 genes encoding IMP-1 MBL, which conferred resistance to carbapenems. The bla IMP-1 genes of P. alcaligenes and P. paralcaligenes were located on the plasmids, pMRCP2, 323125 bp in size, and pMRCP1333, 16592 bp in size, respectively. The sequence of 82 % of pMRCP2 was 92 % similar to the sequence of a plasmid of P. aeruginosa PA83, whereas the sequence of 79 % of pMRCP1333 was >95 % similar to the sequence of a plasmid of Achromobacter xylosoxidans FDAARGOS 162. The genomic environments surrounding the bla IMP-1 of pMRCP2 and pMRCP1333 differed completely from each other.Conclusions. These results indicate that the two isolates acquired bla IMP-1 from different sources and that P. alcaligenes and P. paralcaligenes function as vectors and reservoirs of carbapenem-resistant genes in hospitals.

含bla IMP-1质粒的耐碳青霉烯类碱性假单胞菌和副碱性假单胞菌临床分离株的出现。
介绍。产生金属β-内酰胺酶(MBL)的耐碳青霉烯假单胞菌的出现已成为世界范围内严重的医学问题。日本于1991年首次发现imp型MBL。从那时起,它已经成为最流行的mbl类型之一。假设/差距语句。假单胞菌的无毒种类,如碱性假单胞菌,在临床环境中作为耐药相关基因的储存库,编码碳青霉烯酶。2019年,在日本东京的一家医院对耐碳青霉烯的革兰氏阴性病原体进行了主动监测。在543份碳青霉烯耐药菌株中,2份为假单胞菌。一份来自一名医务人员的粪便样本,另一份来自一名住院病人的粪便样本。全基因组测序结果表明,前者为P. alcaligenes菌株,后者为与P. alcaligenes相近的假单胞菌(Pseudomonas parcaligenes)菌株。这两种分离株均对所有碳青霉烯类具有抗性,并且含有编码IMP-1 MBL的bla IMP-1基因,该基因赋予了对碳青霉烯类的抗性。P. alcaligenes和P. parcaligenes的bla IMP-1基因分别位于pMRCP2、323125 bp和pMRCP1333、16592 bp的质粒上。82%的pMRCP2序列与铜绿假单胞菌PA83的质粒序列相似度为92%,而79%的pMRCP1333序列与木氧化无色杆菌FDAARGOS 162的质粒序列相似度> 95%。pMRCP2和pMRCP1333的bla IMP-1周围的基因组环境完全不同。这些结果表明,这两株分离株获得bla IMP-1的来源不同,碱性假单胞菌和副碱性假单胞菌是医院碳青霉烯耐药基因的载体和储存库。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of medical microbiology
Journal of medical microbiology 医学-微生物学
CiteScore
5.50
自引率
3.30%
发文量
143
审稿时长
4.5 months
期刊介绍: Journal of Medical Microbiology provides comprehensive coverage of medical, dental and veterinary microbiology, and infectious diseases. We welcome everything from laboratory research to clinical trials, including bacteriology, virology, mycology and parasitology. We publish articles under the following subject categories: Antimicrobial resistance; Clinical microbiology; Disease, diagnosis and diagnostics; Medical mycology; Molecular and microbial epidemiology; Microbiome and microbial ecology in health; One Health; Pathogenesis, virulence and host response; Prevention, therapy and therapeutics
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信